Aimee Raleigh is a principal at Atlas Venture, where she builds biotechnology companies and invests in new therapies. She previously advised pharmaceutical and biotechnology companies at L.E.K. Consulting and studied joint biology and osteoarthritis in her doctoral research.
Aimee Raleigh is a principal at Atlas Venture, where she builds biotechnology companies and invests in new therapies. She previously advised pharmaceutical and biotechnology companies at L.E.K. Consulting and studied joint biology and osteoarthritis in her doctoral research.